Each year researchers test thousands of potential cancer drugs on mice with subcutaneous tumors. Few drugs make it to human patients, and the process for finding new therapies is slow, partly ...

Breakthrough nanovaccine uses tumor cell membranes and immune-boosting polymers to enhance personalized cancer immunotherapy, ...

the researchers implanted colon cancer tumors in mice subcutaneously. They then gave mice a nanoparticle vaccine delivered either by IV or subcutaneous injection after seven days and again seven ...

Host mice deficient in IFNγ receptors showed uncontrolled leptomeningeal tumor growth, yet subcutaneous or orthotopic tumors remained unchanged. T cells emerged as the primary source of IFNγ ...

Immunotherapy, exemplified by Opdivo, enhances cancer treatment by targeting malignant cells using the immune system, offering a more precise approach than traditional therapies. The FDA approved ...

Modification of the tumor microenvironment was not seen in mice that received the vaccine via needle injection into the skin (subcutaneous administration). Dubbed "vax-innate" by the scientific ...

About 80% of people with cancer suffer from significant muscle wasting, or loss of muscle tissue, and 30% of these patients die from this condition. New research in mice finds that the severity of ...

Immunotherapy helps the immune system find and kill cancer cells. Some types of PD-1 and PD-L1 inhibitors are available as subcutaneous injections that a cancer care professional injects into fat ...